The binding of apolipoprotein H (β2-Glycoprotein I) to lipoproteins

Prostaglandins and Other Lipid Mediators

Volumn 57, Issue 5-6, 1999, Pages 351-359

  Gambino, Roberto ^a   Ruiu, Gianluca ^b   Pagano, Gianfranco ^a   Cassader, Maurizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

2 Glycoprotein I; Apolipoprotein H; Human serum lipoproteins

Indexed keywords

BETA2 GLYCOPROTEIN 1; LIPOPROTEIN LIPASE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; PROTEIN PROTEIN INTERACTION;

BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; PROTEIN BINDING; ULTRACENTRIFUGATION;

EID: 0032817911     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(99)00010-6     Document Type: Article

References (25)

1. 2 glycoprotein-I. Proc Natl Acad Sci USA. 81:1984;3640-3644.
2. Schultze H.E., Heide K., Haupt H. Über ein bisher unbekanntes nieder molekulares β-globulin des humanserums. Naturwissenschaften. 48:1961;719.
3. Nimpf J., Bever E.M., Bomans P.H.H., et al. Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I. Biochem Biophys Acta. 884:1986;142-149.
4. Schousboe I. β2-glycoprotein I A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway . Blood. 66:1985;1086-1091.
5. 2 glycoprotein-I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J Biol Chem. 25:1983;4765-4770.
6. Kamboh M.I., Ferrel R.E., Sepehrnia B. Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β2-glycoprotein I). Am J Hum Genet. 42:1988;452-457.
7. Sepehrnia B., Kamboh M.I., Adams-Campbell L.L., et al. Genetic studies of human apolipoproteins. VIII. Role of the apolipoprotein H polymorphism in relation to serum lipoprotein concentrations. Hum Genet. 82:1989;118-122.
8. Cassader M., Ruiu G., Gambino R. Influence of apolipoprotein H polymorphism on levels of triglycerides. Atherosclerosis. 110:1994;45-51.
9. Hunt J.E., Simpson R.J., Krilis S.A. Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc Natl Acad Sci USA. 90:1993;2141-2145.
10. Hunt J.E., Krilis S.A. The fifth domain of β2-glycoprotein-I contains a phospholipid binding site (Cys 281-Cys 288) and a region recognized by anticardiolipin antibodies. J Immunol. 152:1994;653-659.
11. McNeil P.H., Simpson R.J., Chesterman C.N., Krilis S.A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation β2-glycoprotein I (apolipoprotein H) . Proc Natl Acad Sci USA. 87:1990;4120-4124.
12. Polz E., Kostner G.M. The binding of β2-glycoprotein-I to human serum lipoproteins. Distribution among density fractions. FEBS Lett. 102:1979;183-186.
13. Burstein M, Legmann P. In: Peeters, H., editor. Protides of the Biological Fluids. New York: Pergamon Press Ltd., 1977. pp. 407-10.
14. Nakaya Y.E., Schaefer E.J., Brewer H.B. Jr. Activation of human post heparin lipoprotein lipase by apolipoprotein H (β2-glycoprotein-I). Biochem Biophys Res Commun. 95:1980;1168-1172.
15. Groot P.H.E., Scheek L.M., Havekes L., van Noort W.L., van't Hooft F.M. A one-step separation of human serum high density lipoproteins 2 and 3 by rate-zonal density gradient ultracentrifugation in a swinging bucket rotor. J Lipid Res. 23:1982;1342-1353.
16. Gambino R., Ruiu G., Cassader M., Pagano G. Apolipoprotein H A two-step isolation method . J Lipid Res. 37:1996;902-904.
17. Steinkasserer A., Estaller C., Weiss E.H., Sim R.B. Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I. Biochem J. 277:1991;387-391.
18. Cassader M., Ruiu G., Gambino R., Veglia F., Pagano G. Apolipoprotein H levels in diabetic subjects Correlation with cholesterol levels . Metabolism. 47:1997;522-525.
19. Shen B.W., Scanu A.M. Properties of human apolipoprotein A-I at the air-water interface. Biochemistry. 19:1980;3643-3650.
20. Morriset J.D., Jackson R.L., Gotto A.M. Jr. Lipid-protein interactions in the plasma lipoproteins. Biochem Biophys Acta. 472:1977;93-133.
21. Scanu AM, Edelstein C, Keim P. In: Putnam FW, editor. The Plasma Proteins. New York: Academic Press, vol. 1. 1975.
22. Vlachoyiannopoulos P.G., Krilis S.A., Hunt J.E., Manoussakis M.N., Moutsopoulos H.M. Patients with anticardiolipin antibodies with and without anti-phospholipid syndrome Their clinical features and β2-glycoprotein-I plasma levels . Eur J Clin Invest. 22:1992;482-487.
23. McNally T., Mackie I.J., Isenberg D.A., Machin S.J. Immunoelectrophoresis and ELISA techniques for assay of plasma β2-glycoprotein-I and the influence of plasma lipids. Thromb Res. 72:1993;275-286.
24. Sansom P.A., Marlow C.T., Lapsley M., Flynn F.V. A sandwich enzyme-linked immunosorbent assay for β2-glycoprotein-I. Ann Clin Biochem. 28:1991;283-289.
25. Day J.R., O'Hara P.J., Grant F.J., et al. Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (β2-Glycoprotein I). Int J Clin Lab Res. 21:1992;256-263.